These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4770896)

  • 1. Clinical trial of a new coronary dilator (verapamil hydrochloride) in ischemic heart disease.
    Husain SA; Saksena HC; Kothari RP; Marothi PS
    Indian J Med Sci; 1973 Aug; 27(8):596-600. PubMed ID: 4770896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nifedipine and verapamil in the treatment of ischemic heart disease and hypertension].
    Metelitsa VI; Slastnikova ID; Matsevich SIu; Kokurina EV; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):113-8. PubMed ID: 2604882
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Sajadieh A; Storm HH; Hansen JF
    Am J Cardiol; 1999 May; 83(9):1419-22, A9. PubMed ID: 10235108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of verapamil on blood viscosity in ischemic heart disease].
    Zochowski RJ; Kochmański M
    Pol Arch Med Wewn; 1987 Sep; 78(3):154-65. PubMed ID: 3271295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Verapamil in ischemic pain and arrhythmia].
    Waris E
    Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease.
    Chew CY; Hecht HS; Collett JT; McAllister RG; Singh BN
    Am J Cardiol; 1981 Apr; 47(4):917-22. PubMed ID: 7211708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 13. [Verapamil in the treatment of patients with coronary insufficiency].
    Savenkov PM; Doscicin VL; Zarov EI; Arsakuni RO
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1287+. PubMed ID: 4098328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term administration of verapamil in coronary disease].
    Tkaczewski W; Goch JH; Bala T; Kuklewicz C
    Pol Tyg Lek; 1977 Oct; 32(44):1719-21. PubMed ID: 917918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly].
    Korkushko OV; Sarkisov KG; Butenko AG
    Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of verapamil on echocardiographic dimensions of the left ventricle in ischemic cardiopathy: comparison with placebo, propranolol and trinitroglycerin].
    Fonzo R; Cherchi A; Bina P; Mercuro G; Lai C; Cioglia G; Sau F
    Boll Soc Ital Cardiol; 1979; 24(6):623-35. PubMed ID: 121796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 20. Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise.
    Balasubramanian V; Khanna PK; Naryanan GR; Hoon RS
    Postgrad Med J; 1976 Mar; 52(605):143-7. PubMed ID: 772647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.